Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

1661 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NeuroBo Pharmaceuticals' DA-1241 in Combination with Semaglutide Improves Liver Fibrosis and Demonstrates Additive Hepatoprotective Effects in Pre-Clinical MASH Models Compared to Either Treatment, Alone
PR
North Korea displays leader's portrait beside predecessors for first time
RE
Transcript : Imunon, Inc., Q1 2024 Earnings Call, May 13, 2024
ACELYRIN, INC. Announces Leadership Transition
GL
ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones
GL
Transcript : Takeda Pharmaceutical Company Limited, 2024 Earnings Call, May 09, 2024
Transcript : Studio Dragon Corporation, Q1 2024 Earnings Call, May 09, 2024
Plus Therapeutics : The use of CNSide in Clinical Management of LMD
PU
HD Hyundai : Heavy Industries Shares Excellence of K-Battleships to the World2024.05.08
PU
North Korean propaganda chief who served all three leaders dies
RE
North Korea bolsters leader Kim with birthday loyalty oaths
RE
Ascendis Pharma A/S : Form 6-K
PU
Plymouth Industrial REIT : Supplemental Q1 2024
PU
NEUROBO TO PRESENT LATEST PRE-CLINICAL DATA ON CARDIOMETABOLIC ASSETS, DA-1241 AND DA-1726, TARGETING MASH AND OBESITY, AT SCIENTIFIC CONFERENCES IN JUNE
AQ
Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
BU
Live Nation Entertainment : Colde Announces Highly Anticipated ‘Blueprint’ Tour Across North America
PU
US Metro Bancorp Announces First Quarter 2024 Results
BU
Daewoo E&C becomes the first domestic construction company to acquire ISO 19443 certification
AQ
North Korea leader Kim Jong Un inspects test-firing of multiple launch rockets, KCNA says
RE
Lotte Chemical Pakistan : Transmission of Quarterly Report for the Period Ended 31 March 2024.
PU
North Korea, Belarus deputy foreign ministers agree to strengthen ties
RE
North Korea releases song praising leader Kim as 'friendly father'
RE
Kona I Co.,Ltd. agreed to acquire remaining stake in Kona M Co., Ltd. from Cho Jeong Il, Cho Nam-hee, Cho Jae-Hyeon, Park Hyeon-cheol, Cho Seong-je, Jun-sang Yoo, Sung Kyung Sik, Park Jeong-rim, Je-soon Park and Kim Mi-seon for KRW38.3 billion.
CI
Explainer-Why is Japan seeking a summit with nuclear-armed North Korea?
RE
North Korea leader Kim Jong Un says now is time to be ready for war, KCNA says
RE
OSE Immunotherapeutics Receives €8.4 M in Public Funding to Support the Registration Phase 3 Clinical Trial of Cancer Vaccine Tedopi® in Lung Cancer
GL
OSE Immunotherapeutics Receives €8.4 M in Public Funding to Support the Registration Phase 3 Clinical Trial of Cancer Vaccine Tedopi® in Lung Cancer
AQ
Transcript : Imunon, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Russian delegation visits Pyongyang to discuss cooperation against spying, KCNA says
RE
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 29.99999658 billion in funding from HLB Co., Ltd. and other investors
CI
Acelyrin : Corporate Presentation
PU
ACELYRIN, INC. Announces Long-term 32-Week Data from the Phase 2b Trial of Izokibep in Hidradenitis Suppurativa Demonstrating Sustained Responses and Deepening Clinical Benefit - Improving Quality of Life for Patients
GL
Canada’s Got Talent Reveals Showstopping Acts for The Million Dollar Season, Courtesy of Rogers
GL
HLB Co., Ltd. announced that it expects to receive KRW 60 billion in funding from a group of investors
CI
South Korea's fertility rate plunges to record low
RE
Transcript : UCB SA, 2023 Earnings Call, Feb 28, 2024
Transcript : Insmed Incorporated, Q4 2023 Earnings Call, Feb 22, 2024
South Korea holds rates steady, investors eye timing of pivot
RE
Transcript : Hanwha Life Insurance Co., Ltd., 2023 Earnings Call, Feb 21, 2024
Fonar Announces Six Months and 2nd Quarter Financial Results for Fiscal 2024
NE
US supports Japan's push for talks with North Korea, envoy says
RE
Transcript : KT&G Corporation, Q4 2023 Earnings Call, Feb 07, 2024
Transcript : Woori Financial Group Inc., 2023 Earnings Call, Feb 06, 2024
US Metro Bancorp Announces Fourth Quarter 2023 Results
BU
'Avatar: The Last Airbender' trailer introduces Netflix series
AQ
North Korea lauds 'comradely' ties with Russia, Putin to meet Kim's foreign minister
RE
Transcript : Precigen, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 05:15 PM
Transcript : Xencor, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03:45 PM
STADA and Alvotech Secure Approval for Uzpruvo, Europe’s First Ustekinumab Biosimilar to Stelara
GL
Transcript : Takeda Pharmaceutical Company Limited Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 05:15 PM
No results for this search
  1. Stock Market
  2. Advanced search
  3. Dae-Il Kim
  4. News